- Presentation
Presentation by Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Stanford Institute for Economic Policy Research.
- Presentation
Presentation by Joseph Kile, CBO’s Director of Microeconomic Analysis, to The Australian Treasury's Macroeconomic Group.
- Presentation
Presentation by Phillip Swagel, CBO’s Director, at the Annual Economic Policy Conference of the National Association for Business Economics.
- Presentation
Presentation by Phillip Swagel, CBO’s Director, to the Prosperity Caucus.
- Presentation
Presentation by David Mosher, CBO’s Director of National Security Analysis, at the Military Manpower Roundtable.
- Presentation
A briefing by Phillip Swagel, CBO’s Director, for the U.S. House of Representatives.
- Presentation
Presentation by Corinne Kramer, an analyst in CBO’s National Security Division, as part of the Global Security Technical Webinar Series at the Massachusetts Institute of Technology.
- Presentation
Presentation by Phillip Swagel, CBO’s Director, to the Republican Members of the House Energy and Commerce Committee.
- Presentation
Presentation by Eric J. Labs, an analyst in CBO’s National Security Division, at the National Defense Industrial Association’s 25th Annual Expeditionary Warfare Conference.
- Presentation
CBO describes how it estimated the budgetary impact of three key prescription drug provisions in the 2022 reconciliation act. In total, those provisions will reduce the federal deficit by $129 billion from 2022 through 2031, CBO estimates.